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The production of extracellular vesicles is a universal mechanism for intercellular
communication that is conserved across kingdoms. Prokaryotes secrete 50–250 nm
membrane vesicles (MVs) in a manner that is regulated by environmental stress and is
thought to promote survival. Since many types of host-derived stress are encountered
during infection, this implies an important role for MV secretion in bacterial pathogenesis.
Accordingly, MVs produced by gram-positive and gram-negative pathogens contain
toxins, virulence factors, and other molecules that promote survival in the host. However,
recent studies have also shown that bacterial MVs are enriched for molecules that
stimulate innate and adaptive immune responses. As an example, MVs may serve
multiple, important roles in regulating the host response to Mycobacterium tuberculosis
(Mtb), an intracellular pathogen that infects lung macrophages and resides within
modified phagosomes. Previously, we demonstrated that Mtb secretes MVs during
infection that may modulate infected and uninfected immune cells. Our present data
demonstrates that Mtb MVs inhibit the functions of macrophages and T cells, but
promote Major Histocompatibility Complex (MHC) class II antigen presentation by
dendritic cells. We conclude that bacterial MVs serve dual and opposing roles in the
activation of and defense against host immune responses to Mtb and other bacterial
pathogens. We also propose that MV secretion is a central mechanism for interspecies
communication between bacteria and host cells during infection.
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INTRODUCTION
Extracellular vesicles have been recognized in recent years as a novel form of intercellular
communication that is conserved across species. Perhaps the most intriguing trend in the field
is the growing number of reports of extracellular vesicle secretion by prokaryotes (Kim et al.,
2015). For simplicity, we will refer to extracellular vesicles produced by bacteria as membrane
vesicles (MVs). The composition and functions of MVs vary across species, but collectively suggest
that MV secretion is a conserved pathway that promotes bacterial survival. Pathogenic bacteria
secrete toxins and virulence factors via MVs, as well as factors that modulate or defend against
host immune responses. Based on these findings, we propose that MV secretion facilitates the
survival of bacterial pathogens in the host microenvironment, and therefore, is essential for
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virulence. In turn, we propose that innate and adaptive immune
responses have evolved to respond to MV-associated cargo
as a readily accessible source of PAMPs (pathogen-associated
molecular patterns) and antigens. The article will discuss how
MVs, such as those secreted by Mycobacterium tuberculosis
(Mtb), participate in intercellular communication between
pathogenic bacteria and the host immune system.
THE BASICS: BIOGENESIS AND
FUNCTIONS OF BACTERIAL MEMBRANE
VESICLES
The first reports of vesicle secretion by bacteria were published
in the 1960’s, but the field has developed substantially in recent
years (Kim et al., 2015). This trend was likely fueled by expanding
interest in exosomes, a type of vesicle released by mammalian
cells, and the recently discovered role of extracellular vesicles
in intercellular communication. Bacterial MVs, which are 20–
300 nm in size, serve as both a secretion and transport system
for proteins, lipids, and nucleic acids. Thus, the functions of
MVs derive from their molecular cargo. Accordingly, the first
phase of research has focused on the purification and analysis
of MVs produced by bacteria in axenic (i.e., single species)
culture, and hundreds of such studies have established that many
different types of bacteria secrete MVs. This includes gram-
negative and gram-positive bacteria as well as pathogenic and
non-pathogenic bacteria (Brown et al., 2015; Schwechheimer and
Kuehn, 2015). Furthermore, MVs can transport their cargo to
recipient cells of the same species, other bacterial species, or
eukaryotic cells. Current evidence suggests diverse and important
roles for bacterial MVs including, but limited to, nutrient
uptake, antimicrobial defense, horizontal gene transfer, biofilm
nucleation, and the trafficking of microbial products such as
virulence factors and toxins during infection (Kim et al., 2015).
Our current understanding of bacterial MV biogenesis is
limited. MVs released by gram-positive and Mycobacterium
species are thought to derive from the plasma membrane, but the
mechanism is unknown (Brown et al., 2015). MVs secreted by
gram-negative bacteria are enriched for LPS (lipopolysaccharide)
and outer membrane proteins indicating that vesicle budding
proceeds from the outer membrane (Schwechheimer and Kuehn,
2015). Several models have been proposed for MV production
by gram-negative bacteria, suggesting that vesicle biogenesis is
regulated bymultiple pathways. The structure or accumulation of
LPS and lipids in the outer membrane are thought to contribute
to membrane curvature and vesicle budding (Kadurugamuwa
and Beveridge, 1995; Haurat et al., 2011; Elhenawy et al., 2016;
Roier et al., 2016). In addition, disruption of crosslinks between
the outer membrane and peptidoglycan layer promote MV
release (Deatherage et al., 2009; Schwechheimer et al., 2014,
2015). Recently, a high-throughput screen of a whole genome
E. coli knockout library identified 171 genes that affect vesicle
biogenesis (Kulp et al., 2015). Interestingly, mutants of oxidative
stress response pathways correlated with a hypovesiculation
phenotype. This finding is consistent with the observation
that MV production is upregulated in response to oxidative
stress (Sabra et al., 2003; MacDonald and Kuehn, 2013; van de
Waterbeemd et al., 2013). MVs are secreted constitutively by
bacteria, but this process is also induced by iron-deprivation,
antimicrobial peptides, and envelope stress (Manning and
Kuehn, 2011; MacDonald and Kuehn, 2013; Prados-Rosales
et al., 2014b). Taken together, current evidence suggests that
MV biosynthesis promotes bacterial survival and adaptation to
environmental stress.
MV SECRETION AT THE HOST-PATHOGEN
INTERFACE
The success of a pathogen depends on its ability to survive and
replicate within the host environment. For this purpose, bacterial
pathogens have evolved mechanisms to acquire nutrients, defend
against host responses, and in some cases, inflict damage upon
host cells. Therefore, one would predict that pathogenic bacteria
employ MVs to respond and adapt to host environment-
derived stress. Several lines of experimental evidence support
this conclusion. First, MV secretion by pathogenic bacteria is
induced by conditions that are experienced during infection such
as reactive oxygen species, iron-deprivation, and antimicrobial
peptides (Manning and Kuehn, 2011; MacDonald and Kuehn,
2013; Prados-Rosales et al., 2014b). Of note, these studies
employed axenic cultures and growth medium that mimicked
host conditions during infection. Second, molecules that are
secreted via MVs promote bacterial survival. For example,
Mtb MVs contain the siderophore mycobactin and support
growth in iron-deficient medium (Prados-Rosales et al., 2014b).
Third, it is widely established that virulence factors and
toxins are secreted via MVs. Examples include heat-labile
enterotoxin (Enterotoxigenic E. coli), anthrax toxin (Bacillus
anthracis), cholera toxin (Vibrio cholerae), listeriolysin O (Listeria
monocytogenes), and alpha-hemolysin (Staphylococcus aureus)
(Horstman and Kuehn, 2000; Rivera et al., 2010; Chatterjee
and Chaudhuri, 2011; Lee et al., 2013). Collectively, these
findings indicate that MV secretion is likely essential for bacterial
virulence.
The functional advantages of MV-mediated secretion include
the sorting, concentration, protection (within the vesicle lumen),
and selective targeting of cargo. MV-mediated secretion also
provides an attractive mechanism to explain how lipids and
membrane proteins are released by bacteria or how pore-forming
toxins traffic to host membranes. Thus, MVs may orchestrate
the trafficking of microbial molecules to specific locations or
host targets during bacterial infection. The secretion of virulence
factors and toxins within MVs has been covered in depth by
several recent reviews (Manning and Kuehn, 2013; Brown et al.,
2015; Kim et al., 2015), so the remainder of this article will
focus on the role of MVs in intercellular communication between
bacterial pathogens and host immune cells.
IMMUNE MODULATION BY BACTERIAL
MEMBRANE VESICLES
The trafficking of microbial components via MVs is not only
pathogen-beneficial. Innate immune responses are directed
toward molecules that are shared by classes of pathogens such
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as gram-negative or gram-positive bacteria. More commonly
known as PAMPs, these molecules are ligands for pattern
recognition receptors (PRRs), activate immune cells, and
elicit the production of pro-inflammatory cytokines (Kumar
et al., 2011). MVs are a rich source of PAMPs, such as
bacterial lipids, proteins, and nucleic acids (Kaparakis-Liaskos
and Ferrero, 2015). As a primary example, LPS is a potent
agonist of TLR4 and a component of the gram-negative outer
membrane. Although TLR4 studies have employed purified LPS
for nearly two decades, the physiological mechanism of LPS
secretion is now known to involve MVs. This finding has been
reported for many species of gram-negative bacteria including
Pseudomonas aeruginosa, Escherichia coli, Neisseria meningitidis,
andHaemophilus influenzae (Wispelwey et al., 1989; Gu and Tsai,
1991; Söderblom et al., 2005; Ellis et al., 2010). MVs produced
by various bacterial species can also activate TLR2 or TLR5,
two other surface PRRs that recognize bacterial lipoproteins
and flagellin, respectively (Bergman et al., 2005; Durand et al.,
2009; Ellis et al., 2010; Cecil et al., 2016; Rappazzo et al., 2016).
In contrast, the response of TLR7, TLR8, and TLR9 to MV-
associated nucleic acids appears to be weak or absent (Ellis et al.,
2010; Cecil et al., 2016). This raises the intriguing possibility that
cell surface TLRs, but not endosomal TLRs, evolved to recognize
bacterial MVs and execute an immediate response to infection.
Other PRRs that respond to extracellular bacteria are localized
in the cytosol, but their discovery prompted the question of
how and why bacterial products translocate to the host cell
cytosol. An explanation was provided by the demonstration that
MVs produced by Helicobacter pylori, Pseudomonas aeruginosa,
Neisseria gonorrhea, and Aggregatibacter actinomycetemcomitans
contain peptidoglycan, fuse with host cell membranes, and
activate NOD1/NOD2 (Kaparakis et al., 2010; Thay et al., 2014).
More recently, it was demonstrated that enterohemorrhagic
E. coli MVs traffic LPS to the cytosol of host cells and activate
non-canonical inflammasome signaling (Vanaja et al., 2016). In
conclusion, vesicle-mediated transport provides a mechanism
for the secretion of membrane-associated PAMPs as well as the
delivery of bacterial components to cytosolic PRRs. PAMPs are
typically indispensible to ensure detection by the innate immune
system, consistent with the fact that MV secretion by bacteria is
ubiquitous and likely essential for growth.
MVs secreted by bacterial pathogens also traffic antigens
and stimulate adaptive immune responses. For example, MVs
produced byNeisseria sp., Salmonella typhimurium,Haemophilus
influenza, Clostridium perfringens, and Vibrio cholerae elicit
antibody and/ or T cell responses when administered to mice
(Bergman et al., 2005; Alaniz et al., 2007; Schild et al., 2009;
Roier et al., 2012; Jiang et al., 2014). In some cases vaccination
with MVs confers protective immunity to subsequent challenges
(Alaniz et al., 2007; Holst et al., 2009; Roier et al., 2012).
The antigenicity of MVs is also highlighted by the recent
approval of Bexsero R©, a N. meningitidis MV-based vaccine, in
Europe and the United States for the prevention of serogroup
B meningococcal disease (Gorringe and Pajon, 2012; Vernikos
and Medini, 2014). Current evidence therefore suggests that
MVs are a significant source of antigens during bacterial
infection. However, this is a relatively understudied area and
major questions remain. In general, MV-associated antigens
are poorly characterized. It will be important to identify the
immunodominant antigens in MVs and determine if MVs are
the primary mechanism for their secretion. Second, antigen
trafficking via MVs has not been broadly characterized for
bacterial pathogens. Thus, it is currently unknown if MVs play
a broad role or limited role in adaptive immune responses during
infection.
To further complicate the picture, there is evidence for
immune evasion by pathogen-derived MVs as well as immune
modulation by commensal-derived MVs (Vidakovics et al., 2010;
Shen et al., 2012; Waller et al., 2016). Nonetheless, our current
knowledge collectively suggests that (1) MVs are a central
mechanism for intercellular communication between bacteria
and host cells during infection, and (2) MV secretion can be
beneficial to the host as well as the pathogen. In other words, the
biochemical composition of MVs is different for each species and
determines whether MV secretion promotes bacterial virulence,
host immunity, or both. Thus, the “net effect” of MV secretion on
disease pathogenesis must be assessed on a case-by-case basis for
each pathogen.
MYCOBACTERIUM TUBERCULOSIS
MEMBRANE VESICLES
MV secretion by Mycobacterium tuberculosis (Mtb) is an
excellent example of how MVs may modulate the host immune
response in both a positive and negative manner. Mtb, the
causative agent of tuberculosis, is an intracellular pathogen
that infects lung macrophages and establishes latent infection
for the lifetime of the host (O’Garra et al., 2013). To create
a niche for survival, Mtb secretes a multitude of factors that
inhibit macrophage effector functions or suppress host immune
responses. For example, secreted virulence factors inhibit phago-
lysosome fusion, allowing Mtb to reside within modified
phagosomes. Another immune evasion mechanism involves
the secretion of cell wall-derived TLR2 agonists. Although the
activation of TLRs typically promotes immunity, prolonged
TLR2 signaling during Mtb infection leads to the production
of immunosuppressive cytokines (e.g., IL-10) and the inhibition
of MHC-II antigen presentation (Harding and Boom, 2010;
Richardson et al., 2015). As a result, the host mounts CD4+ T
cell responses that are sufficient to contain Mtb bacilli within
granulomas, but not eliminate the pathogen. MVs likely serve an
important role in this balance of immunity and immune evasion
that is characteristic of latent Mtb infection.
It was reported in 2011 that pathogenic and non-pathogenic
mycobacteria produce MVs in axenic culture (Prados-Rosales
et al., 2011). Proteomic analysis of Mtb MVs identified 48
proteins and a notable enrichment of lipoproteins which
are potent agonists of TLR2 (Prados-Rosales et al., 2011).
Lipid analysis demonstrated an enrichment of polar lipids,
suggesting that MVs derive from the plasma membrane. MVs
also contained Mtb glycolipids such as phosphatidylinositol
mannosides (PIMs) and lipoarabinomannan (LAM). PIMs are
TLR2 agonists (Harding and Boom, 2010), and LAM inhibits
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phago-lysosome fusion (Fratti et al., 2003). It had been known
for many years that glycolipids and lipoproteins were secreted
by Mtb bacilli, but the molecular mechanism was unknown.
Thus, the discovery of MVs provided a rational explanation for
the release of membrane-associated components from the Mtb
cell wall. More recently, a comprehensive proteomic analysis
identified 287 proteins in Mtb MVs, confirmed the enrichment
of lipoproteins, and discovered dozens of novel MV-associated
factors that impact Mtb pathogenesis (Lee et al., 2015). These
include superoxide dismutase and catalase (virulence factors
involved in protection from oxidative stress) as well as Ag85
and CFP10 (virulence factors and immunodominant T cell
antigens). Aside from lipoproteins, however, the association
of these proteins with Mtb MVs has yet to be validated in
subsequent biochemical or functional studies.
To date, the function of Mtb MVs has largely focused on the
trafficking of TLR2 agonists to immune cells. MVs that were
purified from Mtb axenic cultures and then administered to
macrophages in vitro stimulated TLR2-dependent production
of TNFα, IL-1β, IL-6, and IL-12 (Prados-Rosales et al., 2011).
Furthermore, intratracheal administration of purified Mtb MVs
caused profound inflammation in the lungs of WT, but not
TLR2-deficient mice. In accordance with these findings, the
virR (vesiculogenesis and immune response regulator) Mtb
deletion strain displays a hypervesiculation phenotype and elicits
increased TLR2-dependent production of TNFα and IL-12
during macrophage infection (Rath et al., 2013). Taken together,
these studies strongly implicate a role for MVs in the trafficking
of PAMPs to immune cells.
Very few studies have developed infection models to
study MV production by bacterial pathogens in the host
environment. While investigating the properties of extracellular
vesicles released from Mtb-infected macrophages, however, we
discovered two distinct vesicle subsets—one that contained
classic markers of exosomes and another that contained Mtb
lipoproteins and glycolipids (Athman et al., 2015). We separated
the two populations using density gradients and only the vesicles
bearing Mtb molecules stimulated TLR2-dependent cytokine
responses by uninfected cells. Based on similarities to vesicles
produced by Mtb axenic cultures (Prados-Rosales et al., 2011),
we concluded that Mtb secretes MVs within the phagosome of
infected cells (Figure 1A). In support of this conclusion, MV
secretion could be visualized by electron microscopy for Mtb
bacilli recovered post-infection. Based on our findings we also
concluded that Mtb MVs escape from infected macrophages into
the extracellular environment (Figure 1A). Our work provides
direct evidence for the production of MVs during Mtb infection
and implies that MVs may traffic Mtb molecules to both infected
and uninfected immune cells.
Roles for Mtb MVs within Infected
Macrophages
We propose the followingmodel based on our current knowledge
of MVs produced by Mtb and other pathogens. First, we predict
that MV secretion is upregulated in response to host-derived
stress, such as reduced pH or free radicals, upon Mtb entry
into phagosomes. Once released from Mtb bacilli, MVs traffic
virulence factors to host targets, thereby suppressing macrophage
effector functions and promoting Mtb survival. For example,
MVs may traffic LAM to the phagosomal membrane in order
to block lysosome fusion or traffic lipoproteins to TLR2 in
order to inhibit MHC-II antigen presentation and induce IL-10
production. Mycobactin released within MVs may participate in
iron acquisition during chronic stages of Mtb infection. Thus,
the roles for MVs within Mtb-infected cells are predicted to be
pathogen-beneficial. Mtb strains with a null or hypovesiculation
phenotype are needed to definitively connect MV secretion with
the proposed functions, but are currently unavailable.
Roles for Mtb MVs in the Trafficking of
Microbial Components to Uninfected
Immune Cells
Our recent work has focused on how MVs released from Mtb-
infected macrophages may modulate the functions of uninfected
dendritic cells (DCs), macrophages, and T cells. To simplify
A B
FIGURE 1 | Mtb MVs are secreted during infection and may modulate the functions of infected and uninfected immune cells. (A) Proposed model for the
trafficking of Mtb MVs during macrophage infection (Athman et al., 2015). MVs are secreted by Mtb bacilli within the phagosome; these vesicles are predicted to
suppress macrophage effector functions and promote intracellular Mtb survival. In addition, Mtb MVs are released (mechanism unknown) into the extracellular
environment and traffic to uninfected immune cells. (B) Potential mechanisms for the modulation of uninfected immune cells. Extracellular Mtb MVs may positively
regulate the immune response by trafficking PAMPs and antigens to DCs, thereby promoting antigen presentation and T cell priming in the lymph node. In contrast,
Mtb MVs are predicted to impair MHC-II expression and antigen presentation by uninfected macrophages as well as inhibit CD4+ T cell activation in the lung.
Illustration modified from Athman et al. (2015), The Journal of Immunology. Copyright © 2015, The American Association of Immunologists, Inc.
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FIGURE 2 | Mtb MVs regulate the functions of uninfected immune cells in host- and pathogen-beneficial manners. MV purification: Axenic Mtb cultures
were grown in Sauton’s broth, a defined, minimal medium, to late-log phase. MVs were purified from the conditioned medium by differential ultracentrifugation and gel
filtration chromatography. First, the conditioned medium was centrifuged sequentially at 1000× g and 3000× g for 20min each to remove cells and debris. The
clarified medium was then passed through a 0.45 micron PVDF filter. After filtration, the medium was centrifuged for 2 h at 100, 000× g using the Beckman Ti50.2
rotor. The supernatant was discarded, and the vesicle pellet was resuspended in PBS. Vesicles were further purified using IZON qEV size exclusion columns
according to the manufacturer’s instructions. (A) The size distribution of purified Mtb MVs was determined by TRPS (tunable resistive pulse sensing) using the IZON
qNano system. Instrument settings and data analysis were performed as described (Athman et al., 2015). (B) Whole mount electron microscopy of Mtb MVs was
performed as described (Athman et al., 2015). Note the typical cup-like morphology of extracellular vesicles. Scale bar = 100 nm. (C) Biochemical comparison of Mtb
MVs produced by axenic Mtb cultures (“Ax. MVs”) or during Mtb infection of macrophages (“Inf. EVs”). The purification of infection-derived vesicles, which contain
both Mtb MVs and exosomes, was performed as described (Athman et al., 2015). Western blotting was performed for Mtb lipoproteins (LprG, α1411c mAb; PhoS1,
IT-23 mAb) and LAM (CS-35 mAb) which are markers of Mtb MVs. CD9 is a mammalian protein and marker for exosomes. (D) Mtb MVs induce DC maturation.
Murine bone marrow-derived DCs were cultured for 24 h with no stimuli, 10 nM Pam3CSK4 (TLR2 agonist), or purified Mtb MVs. The expression levels of the antigen
presentation molecules CD86, MHC-I, and MHC-II were determined by cell staining and flow cytometry. Values represent the specific MFI (mean fluorescence
intensity) for CD11b+/CD11c+ cells. “PC” is used as an abbreviation for Pam3CSK4 in the figure only. Statistical significance is shown for treated DCs relative to the
untreated control. Results are representative of 3 independent experiments. (E) Antigen presentation assay. Murine bone marrow-derived DCs were cultured for 24 h
in the absence or presence of gel filtration-purified Mtb MVs. DCs were then cultured for an additional 24 h with the BB7 CD4+ T cell hybridoma. The ratio of DCs to T
cells was 1:1 (100,000 cells each). IL-2 production for duplicate samples was measured using the murine IL-2 ELISA kit from R and D systems. Statistical significance
is shown for IL-2 production in the absence or presence Mtb MVs. Results are representative of 3 independent experiments. (F) Mtb MVs inhibit IFNγ-mediated
induction of MHC-II expression by uninfected macrophages. Murine bone marrow-derived macrophages were prepared as described (Athman et al., 2015) and
treated with no stimuli, 50 ng/mL of Pam3CSK4, or 37–150 ng/mL Mtb MVs for 24 hr. (Note: the dose of MVs was based on total protein.) Cells were then activated
with 2 ng/mL IFNγ for 24 h to induce MHC-II expression. Macrophages were stained using an anti-IA/IE mAb and then analyzed by flow cytometry. Statistical
significance is shown for MV-treated macrophages relative to the control. Results are representative of 3 independent experiments. (D–F) Statistical analyses were
performed using GraphPad Prism software and the two-tailed Students t test. Significance is indicated by asterisks (*p < 0.05; **p < 0.01; ***p < 0.001). Ethics
statement: All animal studies were approved by the Institutional Animal Care and Use Committee of Case Western Reserve University.
the experimental model, we employed MVs that were produced
by axenic Mtb cultures and purified. IZON qNano analysis
(Figure 2A) and electron microscopy (Figure 2B) demonstrate
that axenic culture-derived MVs are similar in size (80–
250 nm) and morphology to those produced during Mtb
infection of macrophages (Athman et al., 2015). The biochemical
composition is also similar; axenic culture- and infection-derived
MVs are enriched for Mtb lipoproteins (LprG, LpqH, Phos1) and
glycolipids (LAM) (Figure 2C & data not shown).
The effect of Mtb MVs on DCs has yet to be addressed.
First, we treated murine DCs with Mtb MVs or the synthetic
TLR2 agonist Pam3CSK4 as a control and determined the effect
on antigen presentation molecules. The expression of MHC-I,
MHC-II, and CD86 were substantially increased, demonstrating
that PAMPs in Mtb MVs induce DC maturation (Figure 2D).
Several immunodominant antigens including Ag85b were
identified as abundant proteins in Mtb MVs (Lee et al., 2015),
so we next determined whether MVs could transfer T cell
Frontiers in Cell and Developmental Biology | www.frontiersin.org 5 November 2016 | Volume 4 | Article 125
Jurkoshek et al. Immune Regulation by Bacterial Membrane Vesicles
antigens to DCs. As shown in Figure 2E, DCs co-cultured with
Mtb MVs and an Ag85b-specific CD4+ T cell hybridoma led
to T cell activation as indicated by IL-2 production. Future
studies are needed to explore the association of Ag85b with
vesicles. Nonetheless, the release of MVs from Mtb-infected
cells may provide a means for uninfected, lymph node DCs to
acquire extracellular antigens, such as Ag85b, and prime CD4+
T cells (Figure 1B) (Srivastava and Ernst, 2014). Consistent with
our findings, Mtb MVs administered to mice were capable of
priming B and T cell responses, although the specific antigens
were not identified in this study (Prados-Rosales et al., 2014a).
In summary, the host may employ extracellular MVs as a
readily accessible source of antigens to generate adaptive immune
responses to Mtb.
In contrast, the extracellular release of Mtb MVs may impair
effector T cell responses at the site of infection, and two
mechanisms may be involved (Figure 1B). First, the treatment of
uninfected macrophages with Mtb MVs inhibits IFNγ–induced
MHC-II expression (Figure 2F). Thus, extracellular Mtb MVs
may traffic to and subsequently impair the antigen presentation
capacity of uninfected macrophages in the lung. The second
mechanism is based on the observation that purified Mtb LAM
inhibits TCR signaling and CD4+ T cell activation (Mahon et al.,
2012; Sande et al., 2016) and that extracellular LAM is secreted
via MVs from Mtb-infected cells (Athman et al., 2015). Our
recent work demonstrates that Mtb MVs are enriched for LAM,
inhibit T cell activation more potently than purified LAM, and
induce T cell anergy (Athman et al., manuscript in revision).
Thus, MVs that are released by Mtb-infected macrophages may
traffic LAM to CD4+ T cells during infection to further suppress
the adaptive immune response. In conclusion, Mtb MVs may
induce innate and adaptive immune responses, but also promote
immune evasion, and latent infection. As extracellular vesicle
research progresses for other pathogens, it will be interesting to
determine whether this is a general paradigm for the role of MVs
in bacterial pathogenesis or a specialized case.
SUMMARY AND PERSPECTIVES
The past decade has seen tremendous growth in the field of
MV research and has changed our viewpoint on fundamental
aspects of microbial life. Although we are just beginning to
understand how and why bacteria produce vesicles, MV secretion
is likely a central mechanism for intercellular communication
between prokaryotic and eukaryotic cells during infection. From
an evolutionary perspective the production of MVs appears to
be an ancient and conserved pathway that promotes the survival
of bacteria, especially under conditions of environmental stress.
In turn, the host immune system may have evolved to recognize
MV-associated molecules as a readily accessible source of PAMPs
and antigens to stimulate innate and adaptive immune responses,
respectively. Thus, MV secretion by bacteria may contribute to
virulence as well as immunity. However, studies to date have
largely characterized MVs produced by axenic bacterial cultures.
It is generally unknown if MVs are secreted during infection
in vitro or in vivo, and if so, how MVs contribute to the
host-pathogen interaction. Furthermore, individual studies have
focused on the properties of bacterial MVs in a context that is
either pathogen- or host-beneficial. To define the physiological
roles of MVs, it will be necessary to assess the “net effect” of MV
secretion on bacterial pathogenesis.
Moving forward, the determination of MV functions,
such as those suggested for Mtb, awaits the development
of new experimental models to study MVs in the context
of infection. More specifically, mutant strains with impaired
vesicle secretion are needed to determine the contribution of
MVs to bacterial virulence and/or the host immune response.
These tools are generally unavailable because of our limited
understanding of MV synthesis pathways. Therefore, a high
priority for the next phase of research is to elucidate the
mechanisms of MV biogenesis for both gram-negative and
gram-positive bacteria. Identification of themolecular machinery
may also provide targets for new classes of antibiotics to
treat bacterial infections or guide the design of MV-based
vaccines.
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